CNS: Gout, Pain/Spasms, HA/Migraines Flashcards
Gout
- deposits of monosodium urate crystals in body tissue
Primary vs Secondary GOUT
primary = caused by an inborn error of purine metabolism
secondary = caused by hyperuricemia that results from other causes; disease states or drugs
Gout PATHO
- overproduction of uric acid
- under excretion of uric acid
Four phases of disease process:
1. asymptomatic hyperuricemia
2. acute gouty arthritis
3. intercritical period
4. development of chronic tophaceous deposits
Gout Hyperuricemia/Risk factors
serum urate level >7mg/dl in men and >6mg/dl in women
Risk factors: men, age >60yo, family hx, med, diet, alcohol consumption, obesity, co-existing medical conditions
Gout Treatment
- treatment - colchicine, corticosteroids, NSAIDs
- Prevention - allopurinol, colchicine, probenecid, pegloticase, febuxostat
patients resistant to conventional tx may require referral to rheumatology
GOAL is PREVENTION
Pretreatment lab
Gout TLC
weight loss
review of current meds
reduce, stop alcohol
dietary changes- low purine diet
significant lifestyle changes can reduce or eliminate need for med
Gout: Colchicine MOA/USES
Used in acute and post acute stages
MOA: reduces deposition of urate crystals
Gout: Colchicine CONTRA/Administration
CONTRA: hypersensitivity, severe renal/GI/hepatic/CV disorders
Onset 12-24 hrs
Dose: initial 0.6-1.2mg, followed by 0.6mg q2hrs until pain relief or diarrhea, max dose 6mg (traditional)
New guidelines: 1.2mg followed in 1hr by 0.6mg = effective and less toxic
Gout: Colchicine AE/INTERACTIONS
AE: GI (significant N/V/D, abd pain), alopecia, B12 malabsorption
Interactions: digoxin, antibiotics, antifungals, antiretrovirals, CCBs, fibrates, grapefruit juice, immunosuppressants, statins
All may INC toxicity
Gout: Colchicine Patient education
- do NOT exceed dose
- follow low purine diet
- NO ETOH
- NO ASA containing meds
- STOP and report: severe vomiting, muscle weakness, watery diarrhea, burning in throat, delirium, convulsions
Gout: Allopurinol USES/MOA
Used to PREVENT future attacks
MOA: inhibits enzyme that converts xanthine to uric acid
Gout: Allopurinol CAUTION/Administration
CAUTION: renal impairment, use of diuretics, ACE inhibitors
Onset 1-2 wks
Dose 200-600mg per day, usual 300mg/day
Adjust for renal clearance
Gout: Allopurinol MONITOR/Patient education
administer w/ large glass of water
MONITOR: start of therapy and during - CBC, serum uric acid, hepatic and renal function
- adequate hydration
- DEC ETOH use
- Low purine diet
- CAUTION w/ OTC meds and vitamins
REPORT signs of liver dysfunction, rash, hair loss, blood in urine
Gout: Probenecid MOA/USES
PREVENTION drug
MOA: inhibit reabsorption of uric acid, promotes excretion and reducing serum uric acid levels
Gout: Probenecid CAUTION/Administration
CAUTION: renal disease, high dose ASA therapy, hx PUD
Dosing: 250mg BID for one week, INC by 500mg per week based on serum uric acid levels
MONITOR: uric acid, renal function, CBC
May take 6 months to reach full effect
Gout: Probenecid AE/INTERACTIONS
AE: flushing, HA, rash, itching, GI, painful urination, anemia
INTERACTIONS: PCN, salicylates, methotrexate, quinolones, cephalosporins, sulfa, acyclovir, BDZ
Gout: Probenecid Patient education
- adequate hydration
- low purine levels
- take w/ food or milk
- AVOID NSAIDs, ASA
REPORT severe HA, rash, bruising, bleeding
Gout: Pegloticase (Krystexxa)
Newest drug for gout
would need to refer patient who require this drug
IV only
Patient must fail to reach normal uric acid levels w/ conventional therapy
CONTRA: patient w/ G6PD deficiency
AE: most common anaphylaxis, infusion reaction, gout flares
Gout: Febuxostat USES/MOA
Uloric
Newest drug for gout
CHRONIC management of gout
MOA: DEC serum uric acid levels
Gout: Febuxostat Administration/INTERACTIONS
Dosing: 40mg/day with goal to 80mg/day
INTERACTIONS: theophylline, mercaptopurine, azathioprine
Gout: Febuxostat CONTRA/AE
CONTRA: can INC initial gouty flares
CAUTION: Hx of CV disease, small # of MI experienced
AE: gouty flares, INC LFT, nausea, arthralgias, rash
Gout: Febuxostat MONITOR/Patient education
NO High fat meals
Antacids will delay absorption
MONITOR: uric acid levels, liver/kidney functions
- low purine diet
- DEC or stop ETOH
- stay hydrated
- report any Hx of CV disease
- possible gouty flares at start of therapy
- drug is new and still expensive
Gout: Clinical Pearls
- diet and weight loss will help patients
- low purine diet
- eliminate ETOH
- check uric acid levels
- check other meds that could precipitate gout attack
- have patients check OTC w/ pharmacist first
Tramadol MOA/USES
- Centrally acting non-narcotic agent
- useful for patients who CANNOT tolerate NSAIDS and do not want to use opiate drugs
Tx moderate to severe pain
small propensity for abuse
PREG C, NO lactation
NO Children (<18yo)
Adjust dose for elderly
Tramadol: CONTRA
acute intoxication w/ ETOH, hypnotics, CNS drugs, opiates, psychotropic drugs
May cause CNS depression
Tramadol: Interactions/AE
Interactions: Carbamazepine, fluoxetine, paroxetine, quinidine, quinine, ritonavir, ETOH, MAOI, SSRI, TCA
AE: flushing, dizziness, HA, insomnia, pruritus, constipation, N/V, dyspepsia, weakness, diaphoresis
Tramadol: Administration
- Immediate release 50-100mg q4-6hr, not exceed 400mg/day
- Extended release 100mg QID, titrate up to 300mg/day
Ultracet: 37.5mg tramadol/325mg acetaminophen, 2 tabs q4-6hrs, max 8 tabs/day
Opioids: USE/MOA
- HIGH abuse potential
- Dose on fixed dosing intervals
Tx moderate to severe pain
PREG C
CAUTION w/ elderly and children
Opioids: AE
- GI: N/V, constipation, xerostomia
- Severe resp depression
- circulatory depression, flushing, shock
- physical & psychological dependence
- sedation, drowsiness
- urinary retention
Skeletal Muscle Relaxants
- centrally acting muscle relaxants
- work in the CNS
- muscle spasms associated w/ low back strain, muscle tenderness, movement disorders
- supportive therapy in fibromyalgia
Muscle Relaxant DRUGS
- cyclobenzaprine (Flexeril)
- carisoprodol (Soma)
- Clorzoxazone (Paraflex, Parafon Forte)
- Metaxalone (Skelaxin)
- Methocarbamol (Robaxin)
- Orphenadrine (Norflex)
Cyclobenzaprine (Flexeril) MOA
MOA: through central action, brainstem; influences alpha and gamma motor neurons
Onset 1hr, duration 12-24hrs
PREG B
NO w/ ETOH, CNS dep
NO children <16yo
Withdraw slowly if using high doses or over prolong period
Cyclobenzaprine CONTRA/AE
CONTRA: hyperthyroidism, MAOI use
Overdose: conduction disturbances, death
AE: CNS dep, anticholinergic activity
Cyclobenzaprine INTERACTIONS/DOSE
Interactions: CNS dep, antimuscarinic meds, tramadol, MAOI, H2 blockers, herbs
Carisoprodol MOA/USE
Addictive qualities: metabolizes to meprobamate
MOA: blocks interneuronal activity and depresses polysynaptic neuron transmission in the spinal cord and reticular formation of the brain
PREG C, NO lactation, NO children <16yo
Carisoprodol CONTRA
CONTRA: CNS dep, Hx of drug or ETOH dependence, seizure disorder
Risk of idiosyncratic reaction: weakness, visual or motor disturbances, confusion, euphoria
Carisoprodol Administration/AE/Interactions
Onset 30 min, duration 4-6hrs
Dose: 350mg TID or QID
use only for SHORT periods, 2-3 wks
AE: drowsiness, dizziness, HA
Interactions: ETOH
Chlorzoxazone MOA
MOA: acts on spinal cord and subcortical levels by depressing polysynaptic reflexes
PREG C
Chlorzoxazone CONTRA/INTERACTIONS
CONTRA: impaired liver function
Interactions: CNS dep, INH, disulfiram, azoles, ETOH
Chlorzoxazone AE/Administration
AE: dizziness, drowsiness, lightheaded, paradoxical stimulation, GI
Onset 1hr, duration 6-12hrs
taper dose
Adults: 250-500mg TID or QID
Peds: 20mg/kg/day
Elderly: half of adult dose
Metaxalone MOA/CONTRA/Interactions
Central muscle relaxant
CONTRA: hepatic or renal dysfunction
NO pregnancy, NO lactation, NO children <12yo
Interactions: CNS dep, benzos, ETOH, TCA
Metaxalone AE/CAUTION
AE: dizziness, HA, nausea, rash, itching, jaundice
elderly more at risk for CNS effects and CNS depression
Death from overdose and w/ ETOH
Metaxalone Administration
dose: 800mg TID to QID
Onset 1hr, duration 4-6hrs
less sedating that other muscle relaxants
Methocarbamol MOA/CONTRA
MOA: causes skeletal muscle relaxation by general CNS depression
CONTRA: renal impairment, seizure disorder, liver impairment
NO children <16yo, PREG C
Supportive therapy in TETANUS
May discolor urine
Methocarbamol AE/INTERACTIONS
AE: drowsiness, dizziness, GI upset, blurred vision, HA
Interactions: CNS dep, ETOH, herbs
Methocarbamol Administration
Onset 30 min, duration 8hrs
Dose: 1.5g BID or TID, max 8g in 24hrs
IV for spasms: 1g q8hrs, no longer than 3 days
Orphenadrine MOA/USE
MOA: centrally acting CNS
Anti-Parkinson’s agent, Anticholinergic agent
PREG C, Adults and children >12yo
Orphenadrine CONTRA/CAUTION
CONTRA: glaucoma, achalasia, GU/GI obstruction, MG
CAUTION: CAD, arrhythmias, asthma
Interactions: haloperidol, amantadine, phenothiazines, MAOI, anticholinergic meds
Orphenadrine AE/Administration
AE: tachycardia, dizziness, syncope, weakness, INC intraocular pressure, urinary retention, blurred vision, dry mouth, GI upset
Dose: 200-250mg/day, usually BID
Onset 1-2hrs, duration 4-6hrs
Pain/Spasms: Adjuvant therapies for PAIN
- TCA - neuropathic pain and chronic pain
- other antidepressants - neuropathic pain and depression
- anti-epilepsy (Gabapentin) - neuropathic pain
- Benzos - skeletal muscle spasms and akathisia
- Anesthetics - Lidoderm patch
Mild to Moderate migraine tx
OTC meds: Excedrin, Tylenol
NSAIDS
Mild to Moderate migraine tx
OTC meds: Excedrin, Tylenol
NSAIDS
Moderate to Severe migraine tx
- Migraine specific: triptans, ergots
- Non-specific narcotics/analgesics:
fioricet, opioids, butalbitals
Triptans MOA